Pherin Pharmaceuticals, Inc. Reports Favorable Clinical, Regulatory, and Intellectual Property Actions on Novel Intranasal Medication for Acute Treatment of Social Anxiety Disorder and Issuance of Patents in the U.S.A. and Other Major Countries
12/6/2012 10:08:37 AM
More...
|